Showing results (1-10 of 392) with videos related to
Sort By:
Pageof 40
Hematology. American Society of Hematology. Education Program|December 6, 2015
Prognostic markers and standard management of chronic lymphocytic leukemiaStephan StilgenbauerHematology. American Society of Hematology. Education Program|January 18, 2011
Understanding and managing ultra high-risk chronic lymphocytic leukemiaStephan Stilgenbauer, Thorsten ZenzHematology/Oncology Clinics of North America|August 25, 2004
Molecular genetics and its clinical relevanceStephan Stilgenbauer, Hartmut DöhnerCurrent Oncology Reports|February 7, 2020
Revolution of Chronic Lymphocytic Leukemia Therapy: the Chemo-Free Treatment ParadigmAnnika Scheffold, Stephan StilgenbauerOncotarget|February 15, 2011
Refractory chronic lymphocytic leukemia--new therapeutic strategiesAndrea Schnaiter, Stephan StilgenbauerTherapeutic Advances in Hematology|April 5, 2013
Novel targeted treatment strategies for refractory chronic lymphocytic leukaemiaAndrea Schnaiter, Stephan StilgenbauerHematology/Oncology Clinics of North America|April 9, 2013
17p deletion in chronic lymphocytic leukemia: risk stratification and therapeutic approachAndrea Schnaiter, Stephan StilgenbauerExpert Opinion on Pharmacotherapy|March 13, 2020
Approved and emerging PI3K inhibitors for the treatment of chronic lymphocytic leukemia and non-Hodgkin lymphomaDirk L Kienle, Stephan StilgenbauerLeukemia & Lymphoma|February 3, 2015
How best to manage patients with chronic lymphocytic leuekmia with 17p deletion and/or TP53 mutation?Constantine S Tam, Stephan StilgenbauerPageof 40